Where the money goes
This year alone more than 30,000 people will be diagnosed with cancer. And we’re doing everything we can to fight it.
Find out just some of the ways your fundraising and donations have helped. And thank you!
We're proud to be the largest voluntary funder of cancer research in Ireland. Since 1963, we've provided over €33 million towards cancer research in universities and hospitals across the country, and we couldn't have done it without your funds and donations. More people are surviving cancer due to cancer research and we continue to fund research that investigates preventing, diagnosing and treating cancer
In 2013 we had an extremely busy year with a large number of research grants being awarded:
- We continued our successful Research Scholarship and Fellowship Programmes and awarded three Research Scholarships and three Research Fellowships to researchers - all of whom are dedicated to cancer research.
- We developed and awarded a new programme of research called the Prostate Cancer Transformative Programme, which is centred around transforming our current knowledge of prostate cancer and advancing current prostate cancer care for patients.
- We were successful in receiving co-funding from the Health Research Board, through the MRCG-HRB Joint Funding Scheme, to fund a Survivorship Research Project focused on head and neck cancer.
- We awarded €7.5 million for establishment of the first Irish Cancer Society Collaborative Cancer Research Centre, BREAST-PREDICT, which the largest research grant we have awarded to date.
Cancer information service
The money we've received funds our free cancer information service. It's staffed by qualified cancer nurses who will talk anyone through anything they want to discuss regarding cancer.
Our survivors supporting survivors programme trains volunteers who have been treated for cancer themselves. They meet cancer patients, share their experience and give them emotional and practical support.
Breast cancer survivors support
In 2010, we launched a pilot programme for breast cancer survivors. The aim of the programme is to reduce the risk of recurrence for cancer survivor